SciVision Biotech Inc
TWSE:1786

Watchlist Manager
SciVision Biotech Inc Logo
SciVision Biotech Inc
TWSE:1786
Watchlist
Price: 90.7 TWD -1.41% Market Closed
Market Cap: 6.4B TWD
Have any thoughts about
SciVision Biotech Inc?
Write Note

SciVision Biotech Inc
Retained Earnings

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

SciVision Biotech Inc
Retained Earnings Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Retained Earnings CAGR 3Y CAGR 5Y CAGR 10Y
SciVision Biotech Inc
TWSE:1786
Retained Earnings
NT$265.9m
CAGR 3-Years
29%
CAGR 5-Years
21%
CAGR 10-Years
46%
M
Medtecs International Corporation Ltd
SGX:546
Retained Earnings
$96.4m
CAGR 3-Years
-15%
CAGR 5-Years
26%
CAGR 10-Years
14%
V
Visco Vision Inc
TWSE:6782
Retained Earnings
NT$1.1B
CAGR 3-Years
45%
CAGR 5-Years
68%
CAGR 10-Years
N/A
P
Pegavision Corp
TWSE:6491
Retained Earnings
NT$5.1B
CAGR 3-Years
31%
CAGR 5-Years
32%
CAGR 10-Years
N/A
OK Biotech Co Ltd
TWSE:4155
Retained Earnings
NT$236.2m
CAGR 3-Years
8%
CAGR 5-Years
9%
CAGR 10-Years
N/A
No Stocks Found

SciVision Biotech Inc
Glance View

Market Cap
6.4B TWD
Industry
Health Care

SciVision Biotech, Inc. engages in the research, development, and production of hyaluronic acid medical products. The company is headquartered in Kaohsiung, Kaohsiung. The company went IPO on 2010-12-29. The firm primarily provides subcutaneous fillers for plastic surgery facial injection, joint cavity injections for orthopedics use, as well as hyaluronic acid raw materials, among others. The firm is also involved in deoxyribonucleic acid (DNA) identification, detection, sequencing and application, as well as the manufacturing of care products and foods. The firm operates its business in the Americas, Europe, Asia, Middle East and Africa.

Intrinsic Value
178.54 TWD
Undervaluation 49%
Intrinsic Value
Price

See Also

What is SciVision Biotech Inc's Retained Earnings?
Retained Earnings
265.9m TWD

Based on the financial report for Sep 30, 2024, SciVision Biotech Inc's Retained Earnings amounts to 265.9m TWD.

What is SciVision Biotech Inc's Retained Earnings growth rate?
Retained Earnings CAGR 10Y
46%

Over the last year, the Retained Earnings growth was 27%. The average annual Retained Earnings growth rates for SciVision Biotech Inc have been 29% over the past three years , 21% over the past five years , and 46% over the past ten years .

Back to Top